These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25351623)

  • 21. Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison.
    Bossler A; Gunsolly C; Pyne MT; Rendo A; Rachel J; Mills R; Miller M; Sipley J; Hillyard D; Jenkins S; Essmyer C; Young S; Lewinski M; Rennert H
    J Clin Virol; 2011 Feb; 50(2):100-3. PubMed ID: 21145783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS
    Braun P; Drago M; Fanti D; Fleury H; Hofmann J; Izopet J; Kühn S; Lombardi A; Micheli V; Sauné K; Trimoulet P; Whittaker D; Artus A; Rhodes D
    J Clin Virol; 2017 May; 90():18-25. PubMed ID: 28319847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ; Majewski DW; Yung B; Mitchell PS; Yao JD
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
    Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
    J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
    Gourlain K; Soulier A; Pellegrin B; Bouvier-Alias M; Hézode C; Darthuy F; Rémiré J; Pawlotsky JM;
    J Clin Microbiol; 2005 Apr; 43(4):1669-73. PubMed ID: 15814982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the VERSANT HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy.
    Germer JJ; Zein NN; Metwally MA; Hoskin TL; Scott Harmsen W; Smith TF; Patel R
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):615-8. PubMed ID: 14711484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).
    Kessler HH; Hübner M; Konrad PM; Stelzl E; Stübler MM; Baser MH; Santner BI
    J Clin Virol; 2013 Nov; 58(3):522-7. PubMed ID: 24095028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Hochberger S; Althof D; Gallegos de Schrott R; Nachbaur N; Röck H; Leying H
    J Clin Virol; 2006 Apr; 35(4):373-80. PubMed ID: 16461000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
    Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
    New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Schumacher W; Frick E; Kauselmann M; Maier-Hoyle V; van der Vliet R; Babiel R
    J Clin Virol; 2007 Apr; 38(4):304-12. PubMed ID: 17329164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of COBAS AmpliPrep/COBAS TaqMan 48 and VERSANT HCV-RNA 3.0 systems for the determination of hepatitis C virus load].
    Kaklikkaya N; Buruk CK; Tosun I; Bayramoğlu G; Ertürk M
    Mikrobiyol Bul; 2009 Oct; 43(4):657-60. PubMed ID: 20084920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.
    Sarrazin C; Hendricks DA; Sedarati F; Zeuzem S
    J Clin Microbiol; 2001 Aug; 39(8):2850-5. PubMed ID: 11474002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verification of the Roche cobas
    Tan NK; Carrington D; Pope CF
    J Med Microbiol; 2018 Dec; 67(12):1711-1717. PubMed ID: 30325300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
    Ikeda H; Okuse C; Watanabe T; Matsumoto N; Matsunaga K; Shigefuku R; Hattori N; Hiraishi T; Fukuda Y; Noguchi Y; Ishii T; Shima J; Nakahara K; Yamamoto H; Yasuda H; Yotsuyanagi H; Koike K; Itoh F; Suzuki M
    Turk J Gastroenterol; 2016 Mar; 27(2):165-72. PubMed ID: 27015621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.
    Forman MS; Valsamakis A
    J Mol Diagn; 2008 Mar; 10(2):147-53. PubMed ID: 18276771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.